Brett N.

Brett N. has extensive work experience in the pharmaceutical and biotechnology industries. Brett is currently the Chief Operating Officer at ClostraBio, Inc, where they oversee the company's operations. Prior to this, they served as the Venture Operations Manager at Portal Innovations, LLC.

Before joining ClostraBio and Portal Innovations, Brett held various roles at Xeris Pharmaceuticals from 2011 to 2020. Brett started as the Director of Product Development before being promoted to Director and then Senior Director of Glucagon Products. In these positions, their responsibilities included commercial planning, portfolio analysis, label development for NDA filings, market research, business development, and due diligence for drug-delivery partnerships. Brett also managed cross-functional teams and led the successful filing of INDs for glucagon pipeline products.

Earlier in their career, Brett worked as a Sr. Bioscience Associate at Austin Technology Incubator and as a Sr. Associate at Texas Venture Labs. Brett gained manufacturing experience at Merck & Co., Inc. as a Manufacturing Facilitator/Supervisor, overseeing the production of bulk vaccines and managing hourly union employees. At GlaxoSmithKline PLC, Brett served as a Biopharmaceutical Manufacturing Associate, supporting the start-up and validation of a manufacturing facility.

Brett's work experience extends beyond the pharmaceutical industry, as they also worked as a Physical Science Technician at USDA-ARS. Their responsibilities included research on biomass thermochemical conversion, gas quantification using GC-MS, and studying decomposition reaction kinetics using MATLAB.

Overall, Brett N. has a diverse background in operations, commercial planning, portfolio management, manufacturing supervision, and scientific research.

Brett N. completed their education in a chronological order starting with their Bachelor of Arts degree in Liberal Arts/Pre-Engineering from Ursinus College, which they obtained from 2000 to 2003. Brett then pursued a Bachelor of Science degree in Chemical Engineering from Columbia University, from 2003 to 2005. Brett continued their education by enrolling in the Texas McCombs School of Business, where they completed their Master of Business Administration (MBA) in Entrepreneurship/Finance from 2009 to 2011.